Top Purchases
The top purchases made by insiders yesterday. Remember, returns and win rates are calculated using the previous purchase trades by the insider.
Director at Bausch Health Companies Inc. ($BHC)
John Paulson (Director) purchased 3,243,049 shares at $6.56/share ($21.27M total) which increased their vested holdings by +9.9%. The current price is $7.17 (+9.3%). Their median purchase size is $42.59M and this is their 3rd largest purchase out of 6 all time. (SEC Source)
Historic Returns
1m returns: +2.4% weighted | 100% win rate (5/5)
3m returns: +34.1% weighted | 100% win rate (3/3)
6m returns: +25.1% weighted | 100% win rate (3/3)
1y returns: +54.0% weighted | 100% win rate (3/3)
Director at Weyerhaeuser Company ($WY)
Sara Grootwassink Lewis (Director) purchased 4,000 shares at $25.29/share ($101.14K total) which increased their vested holdings by +15.7%. The current price is $26.41 (+4.4%). Their median purchase size is $125.71K and this is their 4th largest purchase out of 8 all time. (SEC Source)
Historic Returns
1m returns: +2.2% weighted | 43% win rate (3/7)
3m returns: +11.5% weighted | 57% win rate (4/7)
6m returns: +22.2% weighted | 67% win rate (4/6)
1y returns: +30.3% weighted | 67% win rate (4/6)
Director at Progress Software Corporation ($PRGS)
Rainer Gawlick (Director) purchased 1,710 shares at $43.48/share ($74.35K total) which increased their vested holdings by +3.2%. The current price is $46.11 (+6.0%). Their median purchase size is $62.41K and this is their 2nd largest purchase out of 3 all time. (SEC Source)
Historic Returns
1m returns: +0.8% weighted | 100% win rate (1/1)
3m returns: +6.1% weighted | 100% win rate (1/1)
6m returns: +7.9% weighted | 100% win rate (1/1)
1y returns: +10.4% weighted | 100% win rate (1/1)
Note: 3rd insider purchase at this company in the last 30 days
Top Sales
The top sales made by insiders yesterday. Remember, returns and win rates are calculated using the previous sell trades by the insider. For sell transactions, “win rate” is the percent of profitable trades. If the “win rate” is low, that means the stock typically falls after the insider sells.
Director at Akero Therapeutics, Inc. ($AKRO)
Jane Henderson (Director) sold 3,000 shares at $47.46/share ($142.37K total) which decreased their vested holdings by -12.4%. The current price is $48.31 (+1.8%). Their median sale size is $726.11K and this is their 5th largest sale out of 5 all time. (SEC Source)
Historic Returns
1m returns: +11.1% weighted | 75% win rate (3/4)
3m returns: +0.1% weighted | 50% win rate (2/4)
6m returns: +40.3% weighted | 100% win rate (4/4)
1y returns: +36.5% weighted | 100% win rate (3/3)
Selling the rip (stock was up 95.03% in the year before the sale)
This is the 5th insider sale at this company in the last 30 days (2 others sold on the same day)
Director at Genpact Limited ($G)
Carol Lindstrom (Director) sold 2,326 shares at $43.17/share ($100.41K total) which decreased their vested holdings by -9.9%. The current price is $44.22 (+2.4%). Their median sale size is $133.17K and this is their 12th largest sale out of 19 all time. (SEC Source)
Historic Returns
1m returns: +2.1% weighted | 61% win rate (11/18)
3m returns: +3.5% weighted | 61% win rate (11/18)
6m returns: +6.4% weighted | 65% win rate (11/17)
1y returns: +3.3% weighted | 64% win rate (9/14)
Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.
